Ergoteles LLC Burning Rock Biotech LTD Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.73 - $2.95 $47,498 - $80,995
-27,456 Reduced 35.47%
49,944 $112,000
Q3 2022

Nov 14, 2022
BUY
$2.39 - $3.96 $184,986 - $306,504
77,400 New
77,400 $185,000
Q2 2022

Aug 12, 2022
SELL
$1.75 - $10.44 $91,556 - $546,199
-52,318 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$6.7 - $10.23 $367,843 - $561,647
-54,902 Reduced 51.2%
52,318 $486,000
Q4 2021

Feb 14, 2022
BUY
$9.43 - $17.14 $1.01 Million - $1.84 Million
107,220 New
107,220 $1.02 Million

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $642M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email